<DOC>
	<DOCNO>NCT02224872</DOCNO>
	<brief_summary>Our primary objective determine feasible SAA patient transplant use non-myeloablative conditioning post transplantation cyclophosphamide partially HLA-mismatched donor .</brief_summary>
	<brief_title>Transplantation Partially Mismatched Related Matched Unrelated Bone Marrow Patients With Refractory Severe Aplastic Anemia</brief_title>
	<detailed_description>This research do find bone marrow transplantation ( BMT ) follow chemotherapy help people aplastic anemia fail treatment . You severe , life threaten disease ( severe aplastic anemia ) bone marrow . Your disease come back respond receive one immunosuppressive treatment . High dose chemotherapy follow bone marrow transplantation ( BMT ) use treat blood disease like complication Graft v . Host disease ( GVHD ) graft failure limit survival people . A small study do Johns Hopkins show subject disease ( blood cancer ) immunosuppressive drug give BMT decrease often subject complication GVHD engraftment failure . People aplastic anemia refractory disease ( respond standard treatment ) may join .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Anemia , Aplastic</mesh_term>
	<mesh_term>Pancytopenia</mesh_term>
	<mesh_term>Hemoglobinuria , Paroxysmal</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Fludarabine phosphate</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Fludarabine</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<criteria>Patients relapse refractory SAA SAA define : Bone marrow ( &lt; 25 % cellular ) Peripheral cytopenia ( least 2 3 ) ANC &lt; 500 per ml Platelets &lt; 20,000 per ml Absolute retic &lt; 60,000 correct retic &lt; 1 % Very severe : , ANC &lt; 200 Disease may designate acquire inherited previous count know ( bone marrow failure disorder characterize aplastic anemia may go additional name dyskeratosis congenita PNH ) Failed least one course immunosuppressive therapy ( presume acquire disease ) . Patients inherited disease characterize refractory require immunosuppressive first . Age 0 upper age limit determine current institutional standard Good performance status ( ECOG 0 1 ; Karnofsky Lansky 70100 ) Patients donor must able sign consent form ( minor parent sign ) . Donors willing donate . Patients must geographically accessible willing participate stage treatment . Adequate endorgan function measure : 1 . Left ventricular ejection fraction &gt; = 35 % , shorten fraction &gt; 25 % ( For pediatric patient , normal ejection fraction require ) 2 . Bilirubin ≤ 3.0 mg/dL ( unless due Gilbert 's syndrome hemolysis ) , ALT AST ≤ 5 x ULN 3 . FEV1 FVC &gt; = 40 % predict ; pediatric patient , unable perform pulmonary function test due young age , oxygen saturation &gt; 92 % room air Patients exclude basis sex , racial ethnic background . Prior transfusion select donor ( could cause recipient alloimmunization donor ) Women childbearing potential currently pregnant ( HCG+ ) practice adequate contraception . Patients debilitate medical psychiatric illness would preclude give informed consent receive optimal treatment follow . Uncontrolled viral , bacterial , fungal infection ( HIV infection permit viral load undetectable )</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>73 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>bone marrow transplant</keyword>
	<keyword>thymoglobulin</keyword>
	<keyword>cyclophosphamide</keyword>
	<keyword>fludarabine</keyword>
	<keyword>tacrolimus</keyword>
	<keyword>Mycophenolic Acid Mofetil</keyword>
	<keyword>chemotherapy</keyword>
	<keyword>GVHD</keyword>
	<keyword>haploidentical</keyword>
</DOC>